Colorectal cancer screening procedures are highly underused. We propose an integrated, interdisciplinary, and multi-level approach to understanding and increasing the use of colorectal cancer screening. We will conduct a study with a series of integrated aims to examine who gets screening and what tests they get, why people don't get screening, and what the most cost-effective methods of screening are. The results will be useful in developing new approaches, interventions, and policies to increase screening and in developing new screening methods.
Specific aims are to: (1) Examine the Individual and Area-Level Predictors of Colorectal Cancer Screening Utilization We will use nationally representative data from the National Health Interview Survey and Medical Expenditure Panel Survey that we will link to provider/plan and area-level data. We will focus particularly on the impact of (a) specific health plan characteristics and (b) area-level characteristics. (2) Analyze Patient Preferences for Colorectal Cancer Screening Methods We will use a quantitative and economic-theory based approach as well as a qualitative approach to measuring preferences. We will focus particularly on (a) how much patients value the various attributes of current and new screening tests; (b) how utilization of screening methods is associated with preferences for those methods; and (c) how differences across and within health care insurance systems influence perceptions of screening methods, cost, and willingness-to-pay. (3) Conduct Cost-Effectiveness and Cost-Benefit Analyses of Colorectal Cancer Screening. We will adapt a previously developed, validated cancer screening model to examine the cost-effectiveness and net benefits of colorectal cancer screening methods. We will focus particularly on the influence of (a) utilization rates (Aim #1) and (b) patient preferences for current and new screening methods (Aim #2).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA101849-02
Application #
6890430
Study Section
Health Services Organization and Delivery Study Section (HSOD)
Program Officer
Breen, Nancy
Project Start
2004-04-28
Project End
2008-03-31
Budget Start
2005-04-01
Budget End
2006-03-31
Support Year
2
Fiscal Year
2005
Total Cost
$623,621
Indirect Cost
Name
University of California San Francisco
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Ferrusi, Ilia L; Leighl, Natasha B; Kulin, Nathalie A et al. (2011) Do economic evaluations of targeted therapy provide support for decision makers? J Oncol Pract 7:36s-45s
Ferrusi, Ilia L; Leighl, Natasha B; Kulin, Nathalie A et al. (2011) Do economic evaluations of targeted therapy provide support for decision makers? Am J Manag Care 17 Suppl 5 Deve:SP61-70
Trosman, Julia R; Van Bebber, Stephanie L; Phillips, Kathryn A (2011) Health technology assessment and private payers's coverage of personalized medicine. Am J Manag Care 17 Suppl 5 Deve:SP53-60
Trosman, Julia R; Van Bebber, Stephanie L; Phillips, Kathryn A (2011) Health technology assessment and private payers' coverage of personalized medicine. J Oncol Pract 7:18s-24s
Ladabaum, Uri; Ferrandez, Angel; Lanas, Angel (2010) Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy. Cancer Epidemiol Biomarkers Prev 19:2765-76
Johnson, F Reed; Ozdemir, Semra; Phillips, Kathryn A (2010) Effects of simplifying choice tasks on estimates of taste heterogeneity in stated-choice surveys. Soc Sci Med 70:183-90
Trosman, Julia R; Van Bebber, Stephanie L; Phillips, Kathryn A (2010) Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay. J Oncol Pract 6:238-42
Phillips, Kathryn A; Marshall, Deborah A; Haas, Jennifer S et al. (2009) Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients. Cancer 115:5166-74
Marshall, Deborah A; Johnson, F Reed; Kulin, Nathalie A et al. (2009) How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey. Health Econ 18:1420-39
Liang, Su-Ying; Haas, Jennifer S; Phillips, Kathryn A (2009) Medicare formulary coverage for top-selling biologics. Nat Biotechnol 27:1082-4

Showing the most recent 10 out of 18 publications